ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5

ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5

Author:

Citation: Yang, Y., Gao, Y., Huang, J. et al. ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5. JCI Insight. (2022). https://doi.org/10.1172/jci.insight.157081

Used in this study: Immunodeficient B-NDG Mice

Read entire article

Share:

Back to top